文献速递妇科

阴道子宫切除术中机会性输卵管切除术的风险与获益:一项决策分析

Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
PubMed 文献 · Am J Obstet Gynecol · 2017-06-12

该决策分析模型比较阴道子宫切除术中计划性输卵管切除术与单纯子宫切除术,发现输卵管切除术可预防卵巢癌及死亡且成本更低,但主要并发症略增(7.95% vs 7.68%),结论为应常规行输卵管切除术。

要点

  • 每225例手术预防1例卵巢癌诊断,每450例预防1例卵巢癌死亡。
  • 输卵管切除术成本低于不切除(7350.62美元 vs 8113.45美元)。
  • 主要并发症略增(7.95% vs 7.68%),每预防1例癌症增加0.61次并发症。

核心结论

  • 输卵管切除术应常规与阴道子宫切除术一同进行,因其为优势且具成本效益的策略。
  • 并发症轻度增加,但与癌症预防的权衡高度有利。

研究设计与样本

  • 使用TreeAgePro构建决策分析模型。
  • 并发症率来自已发表文献及2008年至2013年国家手术质量改进计划数据库中13397例阴道子宫切除术。
  • 成本来自已发表文献、 Medicare报销数据及单中心892例子宫切除术的内部成本数据。

主要发现

  • 从单纯阴道子宫切除术转为常规计划性输卵管切除术,每225例手术预防1例卵巢癌诊断,每450例预防1例卵巢癌死亡。
  • 输卵管切除术策略成本低于不切除策略(7350.62美元 vs 8113.45美元)。
  • 计划性机会性输卵管切除术的主要并发症多于单纯子宫切除术(7.95% vs 7.68%)。
  • 常规输卵管切除术每预防1例癌症增加0.61次并发症,每预防1例死亡增加1.21次并发症。
  • 外科医生需承受约3次额外并发症以预防5例癌症诊断,约6次额外并发症以预防5例癌症死亡。

关键数值与推荐

  • 模型并发症包括输血、中转开腹或腹腔镜、需干预的脓肿/血肿、肠梗阻、再入院及30天内再手术。
  • 中转阴道途径者按美国妇产科医师学会指南假定行双侧输卵管切除术,不论治疗分组。
  • 敏感性分析显示成本增加的主要驱动因素是保留输卵管者后续良性附件手术风险增加。

临床怎么用

  • 输卵管切除术应常规与阴道子宫切除术一同进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fallopian tubes are commonly removed during laparoscopic and open hysterectomy to prevent ovarian and tubal cancer but are not routinely removed during vaginal hysterectomy because of perceptions of increased morbidity, difficulty, or inadequate surgical training. OBJECTIVE: We sought to quantify complications and costs associated with a strategy of planned salpingectomy during vaginal hysterectomy. STUDY DESIGN: We created a decision analysis model using TreeAgePro. Effectiveness outcomes included ovarian cancer incidence and mortality as well as major surgical complications. Modeled complications included transfusion, conversion to laparotomy or laparoscopy, abscess/hematoma requiring intervention, ileus, readmission, and reoperation within 30 days. We also modeled subsequent benign adnexal surgery beyond the postoperative window. Those whose procedures were converted from a vaginal route were assumed to undergo bilateral salpingectomy, regardless of treatment group, following American College of Obstetricians and Gynecologists guidelines. Costs were gathered from published literature and Medicare reimbursement data, with internal cost data from 892 hysterectomies at a single institution used to estimate costs when necessary. Complication rates were determined from published literature and from 13,397 vaginal hysterectomies recorded in the National Surgical Quality Improvement Program database from 2008 through 2013. RESULTS: Switching from a policy of vaginal hysterectomy alone to a policy of routine planned salpingectomy prevents a diagnosis of ovarian cancer in 1 of every 225 women having surgery and prevents death from ovarian cancer in 1 of every 450 women having surgery. Overall, salpingectomy was a less expensive strategy than not performing salpingectomy ($7350.62 vs $8113.45). Sensitivity analysis demonstrated the driving force behind increased costs was the increased risk of subsequent benign adnexal surgery among women retaining their tubes. Planned opportunistic salpingectomy had more major complications than hysterectomy alone (7.95% vs 7.68%). Major complications included transfusion, conversion to laparotomy or laparoscopy, abscess/hematoma requiring intervention, ileus, readmission, and reoperation within 30 days. Therefore, routine salpingectomy results in 0.61 additional complications per case of cancer prevented and 1.21 additional complications per death prevented. A surgeon therefore must withstand an additional ∼3 complications to prevent 5 cancer diagnoses and ∼6 additional complications to prevent 5 cancer deaths. CONCLUSION: Salpingectomy should routinely be performed with vaginal hysterectomy because it was the dominant and therefore cost-effective strategy. Complications are minimally increased, but the trade-off with cancer prevention is highly favorable.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cadish LA, Shepherd JP, Barber EL, et al. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis. Am J Obstet Gynecol. 2017. PMID: 28619689. doi:10.1016/j.ajog.2017.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。